Loading...
Loading...
PRCT| Name | Value |
|---|---|
| Revenues | 69.2M |
| Cost of Revenue | 25.0M |
| Gross Profit | 44.2M |
| Operating Expense | 71.6M |
| Operating I/L | -27.4M |
| Other Income/Expense | 2.7M |
| Interest Income | 3.6M |
| Pretax | -24.7M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -24.7M |
PROCEPT BioRobotics Corporation is a surgical robotics company specializing in urology solutions. The company develops, manufactures, and sells the AquaBeam Robotic System, an image-guided surgical robotic system designed for minimally-invasive urologic surgery, particularly for treating benign prostatic hyperplasia (BPH). Their flagship product, the AquaBeam Robotic System, has an install base of 130 units worldwide, with a significant presence in the United States. Additionally, the company offers Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH, providing a comprehensive approach to addressing urological conditions.
